Registry of ongoing Research Projects (RoPS)

Registry database of all ongoing research projects in Switzerland that are approved by the ethics committees

Lead EC
  •  Comitato etico cantonale Ticino
  •  Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
  •  Commission Cantonale d'éthique de la recherche Genève (CCER)
  •  Ethikkommission Nordwest- und Zentralschweiz EKNZ
  •  Ethikkommission Ostschweiz (EKOS)
  •  Kantonale Ethikkommission Bern
  •  Kantonale Ethikkommission Zürich
  • Apply
Type of project
  •  clinical trial
  •  deceased persons
  •  non clinical, involving persons
  •  personal data/biological material
  • Apply
Category
Study phase (clinical trials only)
  •  n/a
  •  phase 1
  •  phase 1/2
  •  phase 2
  •  phase 3
  •  phase 4
  • Apply
multi- / monocentric Clear
Displaying 1 - 20 of 778
BASEC ID Project title Sponsor Approval date multi- / monocentric Principal investigator Investigational sites Type of project Study phase (clinical trials only) Category Lead EC Local EC(s)
2019-00235 PEACE-4
A Phase III trial of acetylsalicylic acid and atorvastatin in patients with castrate-resistant prostate cancer
Gustave Roussy 26.02.2019 multicentric PD Dr. med. Aurelius Omlin Kantonsspital St. Gallen, St. Gallen
Kantonsspital Baden, Baden und Brugg
clinical trial phase 3 B Ethikkommission Ostschweiz (EKOS) Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich
2019-00185 Evaluation of the Duration of Antimicrobial Treatments in Common Infectious Diseases at Three Swiss Tertiary Care Hospitals – a Quality Control Study 06.02.2019 multicentric PD Dr. med. Michael Osthoff Universitätsspital Basel, Basel
Kantonsspital Aarau, Aarau
Kantonsspital St. Gallen, St. Gallen
personal data/biological material Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Ostschweiz (EKOS)
2019-00089 Drug Utilization Study in Patients Receiving Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment due to Diabetic Macular Edema (DME) Allergan plc 22.02.2019 multicentric Dr. med. Katja Hatz Vista Klinik, Binningen
Berner Augenklinik am Lindenhofspital, Bern
personal data/biological material Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich
2019-00038 MK-3475-676: A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette-Guerin (BCG) in Participants More ... Merck Sharp & Dohme Corp. Whitehouse Station, NJ (USA) 05.03.2019 multicentric PD Dr. med. Thomas Hermanns Universitätsspital Zürich, Zürich
Hôpitaux Universitaires de Genève (HUG), Genf
Universitätsspital Basel, Basel
clinical trial phase 3 C Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission Cantonale d'éthique de la recherche Genève (CCER)
2018-02393 LOOP – Long- and midterm outcomes of osteoarticular infections in paediatric patients 06.02.2019 multicentric Prof. Dr. med.Ulrich Heininger UKBB, Basel
Kinderspital Luzern, Luzern
non clinical, involving persons A Ethikkommission Nordwest- und Zentralschweiz EKNZ
2018-02385 Impact of telemedicine activation of patients with polypharmacy: a randomised acceptance and feasibility study in Switzerland.

Shortitle:
Patient Activation for Drug Reviewing by Telemedicine
01.03.2019 multicentric Dr. /Stefan/ Neuner-Jehle University, Institute of Primary Care, Zürich clinical trial A Kantonale Ethikkommission Zürich
2018-02375 CAMG334ACH01-Swiss Quality of life and healthcare impact assessment in a real-world Erenumab treated migraine population Novartis 14.02.2019 multicentric PD Dr. med. Andreas Gantenbein RehaClinic AG, Bad Zurzach
Inselspital Bern, Bern
Spital Thun, Thun
Neurologie am Löwenplatz, Luzern
Schweizer Paraplegiker-Zentrum, Nottwil
Luzerner Kantonsspital, Luzern
Ospedale Regionale di Lugano More ...
non clinical, involving persons A Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ Comitato etico cantonale Ticino Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonal More ...
2018-02325 Sudden cardiac death in congenital heart diseases with a systemic right ventricle 14.02.2019 multicentric Dr Coralie Blanche HUG, Geneva
Centre hospitalier universitaire vaudois, Lausanne
personal data/biological material Commission Cantonale d'éthique de la recherche Genève (CCER) Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
2018-02304 Aftercare of Childhood Cancer Survivors in Switzerland – the ACCS Switzerland project 12.02.2019 multicentric Assoc. Prof. (Canada) Dr. med. / Katrin / Scheinemann Klinik für Kinder und Jugendliche, Kantonsspital Aarau, Aarau
Universitätskinderspital beider Basel, Basel
Kinderspital Luzern, Luzern
non clinical, involving persons A Ethikkommission Nordwest- und Zentralschweiz EKNZ
2018-02286 Precision Retrospective Outcomes (PRO) 21.02.2019 multicentric PD Dr. med. Christophe Perruchoud La Tour Medical Group, Meyrin
Ospedale Regionale di Lugano; Sede Italiano (OIL), Viganello
Mariotti Clivaz – Health Facilitites SA, Bulle
personal data/biological material Commission Cantonale d'éthique de la recherche Genève (CCER) Comitato etico cantonale Ticino Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
2018-02210 SAKK 95/17
A 24 weeks activity program in patients with early breast cancer receiving aromatase inhibitor therapy. A multicenter randomized phase III trial.
SAKK 22.01.2019 multicentric PD Dr. Dr. med. Friedemann Honecker Tumor- und Brustzentrum ZeTuP St. Gallen, St. Gallen
Spital STS AG, Onkologiezentrum Thun- Berner Oberland, Thun
Inselspital, Bern
Centre du Sein de Genève (Rue de Rive et Chemin Beausoleil), Clinique More ...
clinical trial A Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission Cantonale d'éthique de la recherche Genève (CCER) Ethikkommission Ostschweiz (EKOS) Comitato etico cantonale More ...
2018-02185 A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis Eli-Lilly Company 04.02.2019 multicentric Dr. Luc Biedermann Universitätsspital Zürich, Zürich
Inselspital Bern, Bern
Gastroenterologische Praxis Balsiger, Seibold & Partner, Bern
Kantonsspital St. Gallen, St. Gallen
clinical trial phase 3 C Kantonale Ethikkommission Zürich Kantonale Ethikkommission Bern Ethikkommission Ostschweiz (EKOS)
2018-02155 Respiratory epithelial cells and nasal NO from patients with PCD and CF to refine diagnostics and develop personalized ex vivo drug screening. 15.01.2019 multicentric Prof. Dr. med. Philipp Latzin, PhD Inselspital, 3010 Bern non clinical, involving persons A Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich
2018-02139 Outcome and accuracy of joint reconstruction of operative Treatment of distal forearm and radius injuries. 10.01.2019 multicentric Dr.med. Florian Hess Kantonsspital Frauenfeld, Frauenfeld non clinical, involving persons A Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Zürich
2018-02137 Determination of the selenium status of the adult population in Switzerland 14.02.2019 multicentric Céline Fragnière Rime BLV, Bern
Blutspende SRK, Bern
non clinical, involving persons A Kantonale Ethikkommission Bern
2018-02136 A Phase 1/2 Dose Escalation and Combination Cohort Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Efficacy of BMS-986226 (anti-ICOS mAb) Alone or in Combination with Nivolumab or More ... Bristol-Myers Squibb International Corporation 07.03.2019 multicentric PD Dr. Richard Cathomas Kantonsspital Graubünden, Chur
CHUV, Lausanne
clinical trial phase 1/2 C Kantonale Ethikkommission Zürich Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Zürich
2018-02121 Full Action Chain – The Zurich “Out-of-Hospital Cardiac Arrest” Research Project 30.01.2019 multicentric Prof. Dr. med. Dr. rer. nat. Christian Templin UniversitätsSpital Zürich, Zürich personal data/biological material Kantonale Ethikkommission Zürich
2018-02114 A double-blind, placebo-controlled, multi-centre, clinical trial to investigate the efficacy and safety of 12 months of therapy with inhaled colistimethate sodium in the treatment of subjects with non More ... Zambon S.p.A. 13.02.2019 multicentric Prof. Dr. Daiana Stolz University Hospital Basel, Basel
Pneumology and Sleep Medicine, Kantonspital St. Gallen, St. Gallen
clinical trial phase 3 C Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Ostschweiz (EKOS)
2018-02102 COMB157G2399 - An open-label, single arm, multi-center extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with relapsing multiple sclerosis Novartis Pharma Schweiz AG 08.03.2019 multicentric Prof. Dr. med. Tobias Derfuss Universitätsspital, Basel
Ospedale Regionale di Lugano, Lugano
clinical trial phase 3 C Ethikkommission Nordwest- und Zentralschweiz EKNZ Comitato etico cantonale Ticino
2018-02097 A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and
Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902)Versus Pembrolizumab Alone as First-line Intervention in Par More ...
Merck Sharp & Dohme Corp. Whitehouse Station 30.01.2019 multicentric Prof. Dr. med. Reinhard Dummer UniversitätsSpital Zürich, Zürich
Universitätsspital Basel, Basel
clinical trial phase 3 C Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich